- Home
- IINN vs ITRM Comparison
IINN vs ITRM Comparison
Compare IINN & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- ITRM
- Stock Information
- Founded
- IINN 2018
- ITRM 2015
- Country
- IINN Israel
- ITRM Ireland
- Employees
- IINN N/A
- ITRM 14
- Industry
- IINN Medical/Dental Instruments
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- IINN Health Care
- ITRM Health Care
- Exchange
- IINN Nasdaq
- ITRM Nasdaq
- Market Cap
- IINN 23.5M
- ITRM 24.7M
- IPO Year
- IINN 2021
- ITRM 2018
- Fundamental
- Price
- IINN $1.38
- ITRM $1.09
- Analyst Decision
- IINN
- ITRM Strong Buy
- Analyst Count
- IINN 0
- ITRM 1
- Target Price
- IINN N/A
- ITRM $5.00
- AVG Volume (30 Days)
- IINN 150.3K
- ITRM 180.2K
- Earning Date
- IINN 08-15-2024
- ITRM 11-12-2024
- Dividend Yield
- IINN N/A
- ITRM N/A
- EPS Growth
- IINN N/A
- ITRM N/A
- EPS
- IINN N/A
- ITRM N/A
- Revenue
- IINN N/A
- ITRM N/A
- Revenue This Year
- IINN N/A
- ITRM N/A
- Revenue Next Year
- IINN N/A
- ITRM N/A
- P/E Ratio
- IINN N/A
- ITRM N/A
- Revenue Growth
- IINN N/A
- ITRM N/A
- 52 Week Low
- IINN $0.76
- ITRM $0.62
- 52 Week High
- IINN $2.49
- ITRM $2.50
- Technical
- Relative Strength Index (RSI)
- IINN 61.40
- ITRM 55.99
- Support Level
- IINN $1.33
- ITRM $0.81
- Resistance Level
- IINN $1.48
- ITRM $1.07
- Average True Range (ATR)
- IINN 0.10
- ITRM 0.07
- MACD
- IINN -0.00
- ITRM 0.01
- Stochastic Oscillator
- IINN 42.11
- ITRM 100.00
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.